Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis

Serrated polyps (SPs) are precursors to 15% to 20% of colorectal cancers (CRCs). However, there are uncertainties regarding which SPs require surveillance and at what intervals, with recommendations adapted from those for adenomas in the absence of solid evidence. Our aim was to assess which SP risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastrointestinal endoscopy 2024-10, Vol.100 (4), p.605-615.e14
Hauptverfasser: Baile-Maxía, Sandra, Mangas-Sanjuán, Carolina, Ladabaum, Uri, Sánchez-Ardila, Carmen, Sala-Miquel, Noelia, Hassan, Cesare, Rutter, Matthew D., Bretthauer, Michael, Zapater, Pedro, Jover, Rodrigo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 615.e14
container_issue 4
container_start_page 605
container_title Gastrointestinal endoscopy
container_volume 100
creator Baile-Maxía, Sandra
Mangas-Sanjuán, Carolina
Ladabaum, Uri
Sánchez-Ardila, Carmen
Sala-Miquel, Noelia
Hassan, Cesare
Rutter, Matthew D.
Bretthauer, Michael
Zapater, Pedro
Jover, Rodrigo
description Serrated polyps (SPs) are precursors to 15% to 20% of colorectal cancers (CRCs). However, there are uncertainties regarding which SPs require surveillance and at what intervals, with recommendations adapted from those for adenomas in the absence of solid evidence. Our aim was to assess which SP risk characteristics relate to a higher risk of metachronous CRC or advanced polyps. We systematically searched PubMed, Embase, and Cochrane for cohort studies, case-control studies, and clinical trials from inception to December 31, 2023, of CRC or advanced polyps (advanced adenoma [AA] or advanced SP) incidence at surveillance stratified by baseline SP size, dysplasia, location, and multiplicity. We defined advanced SPs as those ≥10 mm or with dysplasia. CRC and advanced polyp incidence per 1000 person-years were estimated. We performed a meta-analysis by calculating pooled relative risks (RRs) using a random-effects model. A total of 5903 studies were reviewed, and 14 were included with 493,949 patients (mean age, 59.5 years; 55% men). The mean follow-up was 4.9 years. CRC incidence per 1000 person-years was 2.09 (95% confidence interval [CI], 1.29-2.90) for advanced SPs, 1.52 (95% CI, 0.78-2.25) for SPs of ≥10 mm, 5.86 (95% CI, 2.16-9.56) for SPs with dysplasia, 1.18 (95% CI, 0.77-1.60) for proximal SPs, 0.52 (95% CI, 0.08-1.12) for ≥3 SPs, 0.50 (95% CI, 0.35-0.66) for nonadvanced SPs, and 0.44 (95% CI, 0.41-0.46) for normal colonoscopy findings. Metachronous CRC risk was higher in advanced SPs versus nonadvanced SPs (RR, 1.84; 95% CI, 1.11-3.04) and versus normal colonoscopy findings (RR, 2.92; 95% CI, 2.26-3.77), in SPs of ≥10 mm versus 
doi_str_mv 10.1016/j.gie.2024.05.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3065986307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016510724032577</els_id><sourcerecordid>3065986307</sourcerecordid><originalsourceid>FETCH-LOGICAL-c235t-a492c0ebac6e864dea1e5a64575aabad6350eb3e5733dcb1166f51692a120d543</originalsourceid><addsrcrecordid>eNp9kc2O1DAQhC0EYoeFB-CCfOSSYMexk8AJrfiTVkJCcLZ67A54SOLg9uxq3oTHxdlZOHKypfqqLFcx9lyKWgppXh3q7wHrRjRtLXQtGvmA7aQYusp03fCQ7USBKi1Fd8GeEB2EEH2j5GN2ofpey1b3O_b7S6CffASXYyI-xsRnzOB-pLjEI3EXp5jQZZi4g8Vh4oUAf7PdPZ-QQlyIw5iLgouP5OIaHE9IxVQ0HkdOmBLkgq9xOq30mgOnE2WcId-hNwFvOSz-7uUKFphOFOgpezTCRPjs_rxk396_-3r1sbr-_OHT1dvryjVK5wraoXEC9-AM9qb1CBI1mFZ3GmAP3ihdVIW6U8q7vZTGjFqaoQHZCK9bdclennPXFH8dkbKdAzmcJliwNGCVMHrojRJdQeUZdSkSJRztmsIM6WSlsNsg9mDLIHYbxAptyyDF8-I-_rif0f9z_F2gAG_OAJZPliqSJRdwqzdsxVsfw3_i_wDDkZ-P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3065986307</pqid></control><display><type>article</type><title>Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Baile-Maxía, Sandra ; Mangas-Sanjuán, Carolina ; Ladabaum, Uri ; Sánchez-Ardila, Carmen ; Sala-Miquel, Noelia ; Hassan, Cesare ; Rutter, Matthew D. ; Bretthauer, Michael ; Zapater, Pedro ; Jover, Rodrigo</creator><creatorcontrib>Baile-Maxía, Sandra ; Mangas-Sanjuán, Carolina ; Ladabaum, Uri ; Sánchez-Ardila, Carmen ; Sala-Miquel, Noelia ; Hassan, Cesare ; Rutter, Matthew D. ; Bretthauer, Michael ; Zapater, Pedro ; Jover, Rodrigo</creatorcontrib><description>Serrated polyps (SPs) are precursors to 15% to 20% of colorectal cancers (CRCs). However, there are uncertainties regarding which SPs require surveillance and at what intervals, with recommendations adapted from those for adenomas in the absence of solid evidence. Our aim was to assess which SP risk characteristics relate to a higher risk of metachronous CRC or advanced polyps. We systematically searched PubMed, Embase, and Cochrane for cohort studies, case-control studies, and clinical trials from inception to December 31, 2023, of CRC or advanced polyps (advanced adenoma [AA] or advanced SP) incidence at surveillance stratified by baseline SP size, dysplasia, location, and multiplicity. We defined advanced SPs as those ≥10 mm or with dysplasia. CRC and advanced polyp incidence per 1000 person-years were estimated. We performed a meta-analysis by calculating pooled relative risks (RRs) using a random-effects model. A total of 5903 studies were reviewed, and 14 were included with 493,949 patients (mean age, 59.5 years; 55% men). The mean follow-up was 4.9 years. CRC incidence per 1000 person-years was 2.09 (95% confidence interval [CI], 1.29-2.90) for advanced SPs, 1.52 (95% CI, 0.78-2.25) for SPs of ≥10 mm, 5.86 (95% CI, 2.16-9.56) for SPs with dysplasia, 1.18 (95% CI, 0.77-1.60) for proximal SPs, 0.52 (95% CI, 0.08-1.12) for ≥3 SPs, 0.50 (95% CI, 0.35-0.66) for nonadvanced SPs, and 0.44 (95% CI, 0.41-0.46) for normal colonoscopy findings. Metachronous CRC risk was higher in advanced SPs versus nonadvanced SPs (RR, 1.84; 95% CI, 1.11-3.04) and versus normal colonoscopy findings (RR, 2.92; 95% CI, 2.26-3.77), in SPs of ≥10 mm versus &lt;10 mm (RR, 2.61; 95% CI, 1.43-4.77) and versus normal colonoscopy findings (RR: 3.52; 95% CI, 2.17-5.69); and in SPs with dysplasia versus normal colonoscopy findings (RR: 2.71; 95% CI, 2.00-3.67). No increase in CRC or advanced polyp risk was found in patients with proximal versus distal SPs, nor in ≥3 SPs versus 1 or 2 SPs. CRC risk is significantly higher in patients with baseline advanced SPs after 4.9 years of follow-up, with risk magnitudes similar to those described for AA, supporting the current recommendation for 3-year surveillance in patients with advanced SPs. [Display omitted]</description><identifier>ISSN: 0016-5107</identifier><identifier>ISSN: 1097-6779</identifier><identifier>EISSN: 1097-6779</identifier><identifier>DOI: 10.1016/j.gie.2024.05.021</identifier><identifier>PMID: 38851458</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenoma - epidemiology ; Adenoma - pathology ; Adenoma - surgery ; Colonic Polyps - epidemiology ; Colonic Polyps - pathology ; Colonic Polyps - surgery ; Colonoscopy ; Colorectal Neoplasms - epidemiology ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - surgery ; Humans ; Incidence ; Neoplasms, Second Primary - epidemiology ; Neoplasms, Second Primary - pathology ; Risk Factors</subject><ispartof>Gastrointestinal endoscopy, 2024-10, Vol.100 (4), p.605-615.e14</ispartof><rights>2024 American Society for Gastrointestinal Endoscopy</rights><rights>Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c235t-a492c0ebac6e864dea1e5a64575aabad6350eb3e5733dcb1166f51692a120d543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0016510724032577$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38851458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baile-Maxía, Sandra</creatorcontrib><creatorcontrib>Mangas-Sanjuán, Carolina</creatorcontrib><creatorcontrib>Ladabaum, Uri</creatorcontrib><creatorcontrib>Sánchez-Ardila, Carmen</creatorcontrib><creatorcontrib>Sala-Miquel, Noelia</creatorcontrib><creatorcontrib>Hassan, Cesare</creatorcontrib><creatorcontrib>Rutter, Matthew D.</creatorcontrib><creatorcontrib>Bretthauer, Michael</creatorcontrib><creatorcontrib>Zapater, Pedro</creatorcontrib><creatorcontrib>Jover, Rodrigo</creatorcontrib><title>Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis</title><title>Gastrointestinal endoscopy</title><addtitle>Gastrointest Endosc</addtitle><description>Serrated polyps (SPs) are precursors to 15% to 20% of colorectal cancers (CRCs). However, there are uncertainties regarding which SPs require surveillance and at what intervals, with recommendations adapted from those for adenomas in the absence of solid evidence. Our aim was to assess which SP risk characteristics relate to a higher risk of metachronous CRC or advanced polyps. We systematically searched PubMed, Embase, and Cochrane for cohort studies, case-control studies, and clinical trials from inception to December 31, 2023, of CRC or advanced polyps (advanced adenoma [AA] or advanced SP) incidence at surveillance stratified by baseline SP size, dysplasia, location, and multiplicity. We defined advanced SPs as those ≥10 mm or with dysplasia. CRC and advanced polyp incidence per 1000 person-years were estimated. We performed a meta-analysis by calculating pooled relative risks (RRs) using a random-effects model. A total of 5903 studies were reviewed, and 14 were included with 493,949 patients (mean age, 59.5 years; 55% men). The mean follow-up was 4.9 years. CRC incidence per 1000 person-years was 2.09 (95% confidence interval [CI], 1.29-2.90) for advanced SPs, 1.52 (95% CI, 0.78-2.25) for SPs of ≥10 mm, 5.86 (95% CI, 2.16-9.56) for SPs with dysplasia, 1.18 (95% CI, 0.77-1.60) for proximal SPs, 0.52 (95% CI, 0.08-1.12) for ≥3 SPs, 0.50 (95% CI, 0.35-0.66) for nonadvanced SPs, and 0.44 (95% CI, 0.41-0.46) for normal colonoscopy findings. Metachronous CRC risk was higher in advanced SPs versus nonadvanced SPs (RR, 1.84; 95% CI, 1.11-3.04) and versus normal colonoscopy findings (RR, 2.92; 95% CI, 2.26-3.77), in SPs of ≥10 mm versus &lt;10 mm (RR, 2.61; 95% CI, 1.43-4.77) and versus normal colonoscopy findings (RR: 3.52; 95% CI, 2.17-5.69); and in SPs with dysplasia versus normal colonoscopy findings (RR: 2.71; 95% CI, 2.00-3.67). No increase in CRC or advanced polyp risk was found in patients with proximal versus distal SPs, nor in ≥3 SPs versus 1 or 2 SPs. CRC risk is significantly higher in patients with baseline advanced SPs after 4.9 years of follow-up, with risk magnitudes similar to those described for AA, supporting the current recommendation for 3-year surveillance in patients with advanced SPs. [Display omitted]</description><subject>Adenoma - epidemiology</subject><subject>Adenoma - pathology</subject><subject>Adenoma - surgery</subject><subject>Colonic Polyps - epidemiology</subject><subject>Colonic Polyps - pathology</subject><subject>Colonic Polyps - surgery</subject><subject>Colonoscopy</subject><subject>Colorectal Neoplasms - epidemiology</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - surgery</subject><subject>Humans</subject><subject>Incidence</subject><subject>Neoplasms, Second Primary - epidemiology</subject><subject>Neoplasms, Second Primary - pathology</subject><subject>Risk Factors</subject><issn>0016-5107</issn><issn>1097-6779</issn><issn>1097-6779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2O1DAQhC0EYoeFB-CCfOSSYMexk8AJrfiTVkJCcLZ67A54SOLg9uxq3oTHxdlZOHKypfqqLFcx9lyKWgppXh3q7wHrRjRtLXQtGvmA7aQYusp03fCQ7USBKi1Fd8GeEB2EEH2j5GN2ofpey1b3O_b7S6CffASXYyI-xsRnzOB-pLjEI3EXp5jQZZi4g8Vh4oUAf7PdPZ-QQlyIw5iLgouP5OIaHE9IxVQ0HkdOmBLkgq9xOq30mgOnE2WcId-hNwFvOSz-7uUKFphOFOgpezTCRPjs_rxk396_-3r1sbr-_OHT1dvryjVK5wraoXEC9-AM9qb1CBI1mFZ3GmAP3ihdVIW6U8q7vZTGjFqaoQHZCK9bdclennPXFH8dkbKdAzmcJliwNGCVMHrojRJdQeUZdSkSJRztmsIM6WSlsNsg9mDLIHYbxAptyyDF8-I-_rif0f9z_F2gAG_OAJZPliqSJRdwqzdsxVsfw3_i_wDDkZ-P</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Baile-Maxía, Sandra</creator><creator>Mangas-Sanjuán, Carolina</creator><creator>Ladabaum, Uri</creator><creator>Sánchez-Ardila, Carmen</creator><creator>Sala-Miquel, Noelia</creator><creator>Hassan, Cesare</creator><creator>Rutter, Matthew D.</creator><creator>Bretthauer, Michael</creator><creator>Zapater, Pedro</creator><creator>Jover, Rodrigo</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202410</creationdate><title>Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis</title><author>Baile-Maxía, Sandra ; Mangas-Sanjuán, Carolina ; Ladabaum, Uri ; Sánchez-Ardila, Carmen ; Sala-Miquel, Noelia ; Hassan, Cesare ; Rutter, Matthew D. ; Bretthauer, Michael ; Zapater, Pedro ; Jover, Rodrigo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c235t-a492c0ebac6e864dea1e5a64575aabad6350eb3e5733dcb1166f51692a120d543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adenoma - epidemiology</topic><topic>Adenoma - pathology</topic><topic>Adenoma - surgery</topic><topic>Colonic Polyps - epidemiology</topic><topic>Colonic Polyps - pathology</topic><topic>Colonic Polyps - surgery</topic><topic>Colonoscopy</topic><topic>Colorectal Neoplasms - epidemiology</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - surgery</topic><topic>Humans</topic><topic>Incidence</topic><topic>Neoplasms, Second Primary - epidemiology</topic><topic>Neoplasms, Second Primary - pathology</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baile-Maxía, Sandra</creatorcontrib><creatorcontrib>Mangas-Sanjuán, Carolina</creatorcontrib><creatorcontrib>Ladabaum, Uri</creatorcontrib><creatorcontrib>Sánchez-Ardila, Carmen</creatorcontrib><creatorcontrib>Sala-Miquel, Noelia</creatorcontrib><creatorcontrib>Hassan, Cesare</creatorcontrib><creatorcontrib>Rutter, Matthew D.</creatorcontrib><creatorcontrib>Bretthauer, Michael</creatorcontrib><creatorcontrib>Zapater, Pedro</creatorcontrib><creatorcontrib>Jover, Rodrigo</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastrointestinal endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baile-Maxía, Sandra</au><au>Mangas-Sanjuán, Carolina</au><au>Ladabaum, Uri</au><au>Sánchez-Ardila, Carmen</au><au>Sala-Miquel, Noelia</au><au>Hassan, Cesare</au><au>Rutter, Matthew D.</au><au>Bretthauer, Michael</au><au>Zapater, Pedro</au><au>Jover, Rodrigo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis</atitle><jtitle>Gastrointestinal endoscopy</jtitle><addtitle>Gastrointest Endosc</addtitle><date>2024-10</date><risdate>2024</risdate><volume>100</volume><issue>4</issue><spage>605</spage><epage>615.e14</epage><pages>605-615.e14</pages><issn>0016-5107</issn><issn>1097-6779</issn><eissn>1097-6779</eissn><abstract>Serrated polyps (SPs) are precursors to 15% to 20% of colorectal cancers (CRCs). However, there are uncertainties regarding which SPs require surveillance and at what intervals, with recommendations adapted from those for adenomas in the absence of solid evidence. Our aim was to assess which SP risk characteristics relate to a higher risk of metachronous CRC or advanced polyps. We systematically searched PubMed, Embase, and Cochrane for cohort studies, case-control studies, and clinical trials from inception to December 31, 2023, of CRC or advanced polyps (advanced adenoma [AA] or advanced SP) incidence at surveillance stratified by baseline SP size, dysplasia, location, and multiplicity. We defined advanced SPs as those ≥10 mm or with dysplasia. CRC and advanced polyp incidence per 1000 person-years were estimated. We performed a meta-analysis by calculating pooled relative risks (RRs) using a random-effects model. A total of 5903 studies were reviewed, and 14 were included with 493,949 patients (mean age, 59.5 years; 55% men). The mean follow-up was 4.9 years. CRC incidence per 1000 person-years was 2.09 (95% confidence interval [CI], 1.29-2.90) for advanced SPs, 1.52 (95% CI, 0.78-2.25) for SPs of ≥10 mm, 5.86 (95% CI, 2.16-9.56) for SPs with dysplasia, 1.18 (95% CI, 0.77-1.60) for proximal SPs, 0.52 (95% CI, 0.08-1.12) for ≥3 SPs, 0.50 (95% CI, 0.35-0.66) for nonadvanced SPs, and 0.44 (95% CI, 0.41-0.46) for normal colonoscopy findings. Metachronous CRC risk was higher in advanced SPs versus nonadvanced SPs (RR, 1.84; 95% CI, 1.11-3.04) and versus normal colonoscopy findings (RR, 2.92; 95% CI, 2.26-3.77), in SPs of ≥10 mm versus &lt;10 mm (RR, 2.61; 95% CI, 1.43-4.77) and versus normal colonoscopy findings (RR: 3.52; 95% CI, 2.17-5.69); and in SPs with dysplasia versus normal colonoscopy findings (RR: 2.71; 95% CI, 2.00-3.67). No increase in CRC or advanced polyp risk was found in patients with proximal versus distal SPs, nor in ≥3 SPs versus 1 or 2 SPs. CRC risk is significantly higher in patients with baseline advanced SPs after 4.9 years of follow-up, with risk magnitudes similar to those described for AA, supporting the current recommendation for 3-year surveillance in patients with advanced SPs. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38851458</pmid><doi>10.1016/j.gie.2024.05.021</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0016-5107
ispartof Gastrointestinal endoscopy, 2024-10, Vol.100 (4), p.605-615.e14
issn 0016-5107
1097-6779
1097-6779
language eng
recordid cdi_proquest_miscellaneous_3065986307
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenoma - epidemiology
Adenoma - pathology
Adenoma - surgery
Colonic Polyps - epidemiology
Colonic Polyps - pathology
Colonic Polyps - surgery
Colonoscopy
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - pathology
Colorectal Neoplasms - surgery
Humans
Incidence
Neoplasms, Second Primary - epidemiology
Neoplasms, Second Primary - pathology
Risk Factors
title Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A02%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20metachronous%20colorectal%20cancer%20or%20advanced%20lesions%20after%20endoscopic%20resection%20of%20serrated%20polyps:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=Gastrointestinal%20endoscopy&rft.au=Baile-Max%C3%ADa,%20Sandra&rft.date=2024-10&rft.volume=100&rft.issue=4&rft.spage=605&rft.epage=615.e14&rft.pages=605-615.e14&rft.issn=0016-5107&rft.eissn=1097-6779&rft_id=info:doi/10.1016/j.gie.2024.05.021&rft_dat=%3Cproquest_cross%3E3065986307%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3065986307&rft_id=info:pmid/38851458&rft_els_id=S0016510724032577&rfr_iscdi=true